These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29359533)

  • 21. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India.
    Williams JR; Foss AM; Vickerman P; Watts C; Ramesh BM; Reza-Paul S; Washington RG; Moses S; Blanchard J; Lowndes CM; Alary M; Boily MC
    Sex Transm Infect; 2006 Oct; 82(5):372-80. PubMed ID: 17012512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and facilitators to the uptake of voluntary medical male circumcision (VMMC) among adolescent boys in KwaZulu-Natal, South Africa.
    George G; Strauss M; Chirawu P; Rhodes B; Frohlich J; Montague C; Govender K
    Afr J AIDS Res; 2014; 13(2):179-87. PubMed ID: 25174635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
    Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating male circumcision coverage in 15 priority countries in sub-Saharan Africa.
    Stegman PM; Yee R; Davis J; Tchuenche M; Linder R; Zembe L; Frescura L; Kripke KE
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25789. PubMed ID: 34546643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards an improved investment approach for an effective response to HIV/AIDS.
    Schwartländer B; Stover J; Hallett T; Atun R; Avila C; Gouws E; Bartos M; Ghys PD; Opuni M; Barr D; Alsallaq R; Bollinger L; de Freitas M; Garnett G; Holmes C; Legins K; Pillay Y; Stanciole AE; McClure C; Hirnschall G; Laga M; Padian N;
    Lancet; 2011 Jun; 377(9782):2031-41. PubMed ID: 21641026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana.
    Marukutira T; Scott N; Kelly SL; Birungi C; Makhema JM; Crowe S; Stoove M; Hellard M
    PLoS One; 2020; 15(1):e0226422. PubMed ID: 31940360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.
    Marukutira T; Stoové M; Lockman S; Mills LA; Gaolathe T; Lebelonyane R; Jarvis JN; Kelly SL; Wilson DP; Luchters S; Crowe SM; Hellard M
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29508945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
    Stuart RM; Grobicki L; Haghparast-Bidgoli H; Panovska-Griffiths J; Skordis J; Keiser O; Estill J; Baranczuk Z; Kelly SL; Reporter I; Kedziora DJ; Shattock AJ; Petravic J; Hussain SA; Grantham KL; Gray RT; Yap XF; Martin-Hughes R; Benedikt CJ; Fraser-Hurt N; Masaki E; Wilson DJ; Gorgens M; Mziray E; Cheikh N; Shubber Z; Kerr CC; Wilson DP
    J Int AIDS Soc; 2018 Apr; 21(4):e25097. PubMed ID: 29652100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam.
    Blenkinsop A; Monod M; van Sighem A; Pantazis N; Bezemer D; Op de Coul E; van de Laar T; Fraser C; Prins M; Reiss P; de Bree GJ; Ratmann O;
    Elife; 2022 Aug; 11():. PubMed ID: 35920649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and impacts of scaling up voluntary medical male circumcision in Tanzania.
    Menon V; Gold E; Godbole R; Castor D; Mahler H; Forsythe S; Ally M; Njeuhmeli E
    PLoS One; 2014; 9(5):e83925. PubMed ID: 24802022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping male circumcision for HIV prevention efforts in sub-Saharan Africa.
    Cork MA; Wilson KF; Perkins S; Collison ML; Deshpande A; Eaton JW; Earl L; Haeuser E; Justman JE; Kinyoki DK; Mayala BK; Mosser JF; Murray CJL; Nkengasong JN; Piot P; Sartorius B; Schaeffer LE; Serfes AL; Sligar A; Steuben KM; Tanser FC; VanderHeide JD; Yang M; Wabiri N; Hay SI; Dwyer-Lindgren L
    BMC Med; 2020 Jul; 18(1):189. PubMed ID: 32631314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.
    Kripke K; Chen PA; Vazzano A; Thambinayagam A; Pillay Y; Loykissoonlal D; Bonnecwe C; Barron P; Kiwango E; Castor D; Njeuhmeli E
    PLoS One; 2016; 11(7):e0157071. PubMed ID: 27409079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography.
    Hankins C; Warren M; Njeuhmeli E
    PLoS One; 2016; 11(10):e0160699. PubMed ID: 27783613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.
    GBD 2017 HIV collaborators
    Lancet HIV; 2019 Dec; 6(12):e831-e859. PubMed ID: 31439534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling of HIV prevention and treatment progress in five South African metropolitan districts.
    van Schalkwyk C; Dorrington RE; Seatlhodi T; Velasquez C; Feizzadeh A; Johnson LF
    Sci Rep; 2021 Mar; 11(1):5652. PubMed ID: 33707578
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.